Eine Studie hat die medikamentösen Folgen der Konsulation von Kopfschmerzspezialisten durch Migränepatienten untersucht.
Die Ergebnisse:
- Vor der Konsulation nahmen 48,7% der Betroffenen Triptane und 30,9% Migräne-Prophylaktika ein.
- Nach der Konsulation nahmen 97,2% der Betroffenen Triptane und 70,4% Migräne-Prophylaktika ein.
- 20,8% litten unter Medikamentenübergebrauchskopfschmerz, 42,4% davon durch Opiate (auch in Kombinationspräparaten) und 21,6% durch Triptane.
Die medikamentösen Änderungen durch die Konsultation bestanden in einem starken Anstieg der Verschreibungen für Triptane und Migräne-Prophylaktika.
Abstract:
Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada
Jelinski SE, Becker WJ, Christie SN, Giammarco R, Mackie GF, Gawel MJ, Eloff AG & Magnusson JE.
We set out to examine selected clinical characteristics of migraine patients referred to neurologists specializing in headache in Canada, and to document their pharmacological therapy both before and after consultation with the neurologist. Demographic, clinical and pharmacotherapy data were collected at the time of consultation for 606 patients referred to five headache clinics and who were given a migraine diagnosis by the neurologist. Data were analysed as part of the Canadian Headache Outpatient Registry and Database (CHORD) Project. The mean age of the migraine patients was 39.7 years; and 82.5% were female. The majority of patients suffered severe impact from their headaches. Prior to consultation, 48.7% were taking a triptan; after consultation, 97.2% were on a triptan. Before consultation, 30.9% were on a prophylactic drug; after consultation, 70.4% were. 20.8% of patients were medication overusers. Of these medication overusers, 42.4% were overusing an opiate, usually in combination with other analgesics; 21.6% were overusing a triptan. Medication changes made by the neurologists at consultation included a large increase in the use of both triptans and prophylactic medications. Medication overuse, particularly opiate overuse, remains a significant problem in patients with migraine in Canada.
Weitere Infos finden sich hier.
Anmerkung von migraeneinformation.de:
Auch in Deutschland sieht die Praxis vermutlich ganz ähnlich aus. Allerdings dürfte es hier weniger Migränepatienten mit Medikamentenübergebrauchskopfschmerz durch Opiate geben.
